Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The investment will increase commercial output of the company’s Borstar Nextension line.
January 20, 2026
By: Charlie Sternberg
Associate Editor
Borealis AG will invest €49 million (about $53 million) to expand production of advanced polypropylene grades at its manufacturing site in Burghausen, Germany, as demand grows for higher‑performance and more recyclable plastic materials.
The investment will increase commercial output of the company’s Borstar Nextension line, a next‑generation single‑site polypropylene designed to offer higher purity, improved processability and enhanced performance compared with conventional grades. Borealis said the additional capacity is intended to support customers in packaging, healthcare, mobility and fiber applications, sectors that are facing tighter regulatory requirements and increasing sustainability targets.
At the core of the expansion is a shift toward so‑called monomaterial polypropylene solutions. Borstar Nextension technology allows multiple performance characteristics—such as strength, clarity and sealing behavior—to be combined within a single material, reducing the need for complex multilayer structures that are difficult to recycle. Chemical producers and packaging manufacturers have increasingly focused on such designs as regulators and brand owners push to simplify materials and improve recyclability.
Borealis said the technology could enable substitution of multilayer packaging with lighter, single‑polymer alternatives, potentially reducing material use while maintaining performance. Industry analysts note that single‑polyolefin structures are gaining traction as companies seek to balance cost, performance and end‑of‑life considerations.
The company pointed to packaging as a key application area, citing the European Union’s forthcoming Packaging and Packaging Waste Regulation, which includes a target for all packaging on the EU market to be recyclable by 2030. According to Borealis, its Borstar Nextension polypropylene grades are already being adopted in flexible packaging applications, where manufacturers are seeking to meet recyclability requirements without sacrificing processing efficiency or product quality.
“By scaling up Borstar Nextension PP production, we empower our customers to stay ahead in a rapidly changing regulatory and market landscape. It’s another example of our commitment to increase the availability of innovative, recyclable polymer materials suitable for a wide range of applications across multiple industries,” says Craig Arnold, Borealis EVP Polyolefins, Circular Economy Solutions and Base Chemicals.
Read about how companies can balance sustainability with other considerations in pharma packaging.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !